Mikael Dolsten - 26 Feb 2022 Form 4 Insider Report for PFIZER INC (PFE)

Role
President R&D
Signature
Susan E. Grant, by power of atty., for Mikael Dolsten
Issuer symbol
PFE
Transactions as of
26 Feb 2022
Transactions value $
-$1,419,384
Form type
4
Filing time
01 Mar 2022, 15:01:23 UTC
Previous filing
25 Feb 2022
Next filing
04 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Tax liability -$1,419,383 -29,744 -9.2% $47.72 294,118 26 Feb 2022 Direct F1, F2
holding PFE Common Stock 1,818 26 Feb 2022 By Rule 16b-3 Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the withholding of shares to satisfy tax obligations upon the settlement of stock units from previously exercised stock appreciation rights (including dividend equivalents thereon).
F2 Price is the closing price of Pfizer common stock on February 25, 2022.